The regulator said Anatoly's promoter failed to disclose his links to a corporate agent whose licence renewal was refused in 2025 over false declarations and net-worth violations.
The questionnaire seeks views on whether the claimed public benefits are sufficient to outweigh the competition concerns that have twice derailed the transaction.
The expanded offering comes as regulators and corporates across Asia-Pacific show growing interest in captives and other alternative risk-transfer mechanisms.
The deal values the Australian retirement income business at approximately A$7.94bn (US$5.53bn) and follows Dai-ichi Life's proposed acquisition of New Zealand's Fidelity Life.
The electric two-wheeler manufacturer is seeking to expand its revenue streams by leveraging its existing customer base to distribute insurance products under a composite corporate agent licence.
Malaysia’s RHB says talks on selling its insurance arm have made “meaningful progress”, but the parties still need to finalise the transaction terms and documents.
The insurer is pursuing acquisitions through Singlife as it seeks to build scale across Southeast Asia, with Thailand, Malaysia and the Philippines also identified as potential growth markets.
